SAN CARLOS, CA, March 4, 2024 -- Glycomine, Inc., a biotechnology company focused on developing new therapies for orphan diseases, announced the presentation of summary findings from its ongoing Phase...
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
News | 03. 19. 2013
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.